Melissa B, Epperly - Net Worth and Insider Trading
Melissa B, Epperly Net Worth
The estimated net worth of Melissa B, Epperly is at least $2 Million dollars as of 2024-11-29. Melissa B, Epperly is the CFO of Zentalis Pharmaceuticals Inc and owns about 451,449 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $2 Million. Details can be seen in Melissa B, Epperly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Melissa B, Epperly has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Melissa B, Epperly
Melissa B, Epperly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Melissa B, Epperly owns 4 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) , Kinnate Biopharma Inc (KNTE) , and Nautilus Biotechnology Inc (NAUT) among others .
Click here to see the complete history of Melissa B, Epperly’s form 4 insider trades.
Insider Ownership Summary of Melissa B, Epperly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-02-12 | Chief Financial Officer |
| KNTE | Kinnate Biopharma Inc | 2020-12-02 | director |
| NAUT | Nautilus Biotechnology Inc | 2021-06-09 | director |
 | | 2022-06-29 | director |
Melissa B, Epperly Latest Holdings Summary
Melissa B, Epperly currently owns a total of 1 stock. Melissa B, Epperly owns 451,449 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of February 12, 2024, with a value of $2 Million.
Latest Holdings of Melissa B, Epperly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-02-12 | 451,449 | 3.63 | 1,638,760 |
Holding Weightings of Melissa B, Epperly
Melissa B, Epperly Form 4 Trading Tracker
According to the SEC Form 4 filings, Melissa B, Epperly has made a total of 16 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 2 buys and 14 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 2,573 shares on February 12, 2024, which brought Melissa B, Epperly around $29,435.
Insider Trading History of Melissa B, Epperly
- 1
Melissa B, Epperly Trading Performance
GuruFocus tracks the stock performance after each of Melissa B, Epperly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Melissa B, Epperly is 64.32%. GuruFocus also compares Melissa B, Epperly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Melissa B, Epperly within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Melissa B, Epperly's insider trading performs compared to the benchmark.
Performance of Melissa B, Epperly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.7 | | | | | |
| Relative Return to S&P 500(%) | 30.22 | | | | | |
Melissa B, Epperly Ownership Network
Melissa B, Epperly Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Melissa B, Epperly is the Chief Financial Officer of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include General Counsel Andrea Paul , Chief Medical Officer Carrie Brownstein , and Chief Operating Officer Kevin D. Bunker .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Melissa B, Epperly made 3 insider transaction in Zentalis Pharmaceuticals Inc (ZNTL) with a net sale of 16,724. Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net purchase of 17,000 shares made by David Michael Johnson , and a net sale of 10,628 shares made by Carrie Brownstein .
In summary, during the past 3 months, insiders sold 1,603 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 1,603 shares. During the past 18 months, 98,364 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 76,364 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
Melissa B, Epperly Mailing Address
Above is the net worth, insider trading, and ownership report for Melissa B, Epperly. You might contact Melissa B, Epperly via mailing address: C/o Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
